Select Medical Holdings (SEM) Tops Q3 EPS by 5c; maintains guidance

Select Medical Holdings (NYSE: SEM) reported Q3 EPS of $0.46, $0.05 better than the analyst estimate of $0.41. Revenue for the quarter came in at $1.67 billion versus the consensus estimate of $1.63 billion.

GUIDANCE:

Select Medical Holdings sees FY2023 EPS of $1.85-$2.02, versus the consensus of $1.98. Select Medical Holdings sees FY2023 revenue of $6.55-6.7 billion, versus the consensus of $6.623 billion.

For earnings history and earnings-related data on Select Medical Holdings (SEM) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lennar Corp. (LEN) Misses Q2 EPS by 1c
• RH (RH) Tops Q1 EPS by 12c